secwatch.observer — SEC 8-K summary
======================================

Issuer:     MACROGENICS INC (MGNX)
CIK:        0001125345
Form:       8-K
Filed at:   2026-05-12T12:00:15+00:00
Accession:  0001125345-26-000035
Event type: m_and_a
Sentiment:  positive
Materiality: 0.85
Item codes: 1.01, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

MacroGenics sells GMP manufacturing operations to Bora Pharma for $122.5M upfront
--------------------------------------------------------------------------------

- Bora pays $122.5M cash at closing for MacroGenics' CDMO business, including Rockville site (11,000 L capacity) and Frederick warehouse.
- Up to $5M in additional milestone payments to MacroGenics based on 2027-2028 CDMO manufacturing and professional development services.
- Approximately 140 MacroGenics employees expected to be hired by Bora; transaction expected to close in Q3 2026.
- MacroGenics will enter supply and transition services agreements to retain clinical manufacturing support for its pipeline.
- Transaction approved by both boards; subject to customary closing conditions and consents.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1125345/000112534526000035/0001125345-26-000035-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1125345/000112534526000035/mgnx-20260511.htm
  HTML page:      https://secwatch.observer/filing/0001125345-26-000035

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer